WST
West Pharmaceutical Services, Inc.
B-
67.7 / 100 composite
AlphaQuality composite grade, weighted for stable earnings power businesses.
-
5yr Avg ROIC
14.9%
-
Operating Margin Trend
-1.93 pp/yr
-
5yr Avg ROE
17.8%
-
5yr Share-Count CAGR
-1.2%
-
5yr Revenue CAGR
2.1%
-
5yr EPS CAGR
-5.9%
-
Revenue-Growth Years (5)
4/5
-
5yr FCF Margin
13.2%
-
5yr FCF/NI Conversion
0.69x
-
Net Debt / EBITDA
-0.52x
-
Interest Coverage (EBIT/Int)
998.67x
-
Altman Z-Score
15.55
Stability
Weight: 15%
C
51
-
EPS Volatility (σ/μ)
0.57
-
Piotroski F-Score
6
-
Negative-Revenue Years (5)
1/5
5 of 5 gurus held; 5 added.
- Holders
- 5
+1
- Avg Δ position
-
+6227.3%
- New buys
- 0
- Full exits
- 0